Protalix Biotherapeutics Inc (PLX)
P/OCF Ratio
20.72×
TTM · Retrieved:
PLX P/OCF Ratio
Current (TTM)20.72×retrieved
Current (TTM)20.72×retrieved
PLX Quarterly P/OCF Ratio (-364.29× → -17.92×)
Latest values, visible window
High-resolution chart · PNG
PLX p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| -17.92× | |
| 7.8671× | |
| 69.6469× | |
| -47.1611× | |
| -22.2478× | |
| -38.7755× | |
| 34.6465× | |
| 18.2755× | |
| -23.7591× | |
| 21.7995× | |
| 36.1209× | |
| -17.4199× | |
| 27.0095× | |
| -40.2628× | |
| -26.9398× | |
| -5.6005× | |
| -7.013× | |
| -8.3143× | |
| -7.4024× | |
| -32.2292× | |
| 13.3187× | |
| -18.1112× | |
| -15.8008× | |
| -35.2896× | |
| -15.6936× | |
| -5.7391× | |
| -13.2001× | |
| -9.4365× | |
| -13.4891× | |
| -8.8445× | |
| -11.5173× | |
| 8.0945× | |
| -7.9175× | |
| -8.3345× | |
| 5.2501× | |
| -7.2947× | |
| -12.391× | |
| -20.0901× | |
| -7.5483× | |
| -16.5255× | |
| -5.4606× | |
| -8.7077× | |
| -26.1519× | |
| -12.8007× | |
| -34.1542× | |
| -25.8368× | |
| -35.1125× | |
| -23.5638× | |
| -51.9701× | |
| -50.9001× | |
| -75.9214× | |
| -50.9647× | |
| -58.2767× | |
| -52.7947× | |
| 261.9511× | |
| -60.3395× | |
| 39.9624× | |
| -89.0644× | |
| -65.4798× | |
| -48.324× | |
| -111.0783× | |
| -124.6263× | |
| -101.577× | |
| -72.6396× | |
| -41.8474× | |
| -59.293× | |
| 9.0535× | |
| -116.8704× | |
| -105.2139× | |
| -25.3922× | |
| -62.4154× | |
| -26.7501× | |
| -56.5065× | |
| -52.372× | |
| -64.2301× | |
| -1,405.2516× | |
| -845.0946× | |
| -715.1715× | |
| -217.9837× | |
| -9,781.9278× | |
| -138,549.0676× | |
| -14,930.6723× | |
| -48,552.2531× | |
| -409.3924× | |
| -323.2711× | |
| -152.8298× | |
| -37.9807× | |
| -16.9193× | |
| -20.1182× | |
| -8.8051× | |
| -48.1586× | |
| -25.5637× | |
| -20.4413× | |
| -8.8971× | |
| -12.2146× | |
| -20.5247× | |
| -18.9697× | |
| -17.7951× | |
| -0.5059× | |
| -26.0474× |